Antisynthetase syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:81M35.8
Who is this for?
Show terms as
5Active trials35Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Antisynthetase syndrome (also sometimes called anti-synthetase syndrome or ASS) is a rare autoimmune disease. This means the body's immune system mistakenly attacks its own healthy tissues. The disease gets its name from special proteins called aminoacyl-tRNA synthetases — the immune system produces antibodies that target these proteins, causing widespread inflammation. The syndrome mainly affects the muscles, lungs, joints, and skin. The most serious complication is interstitial lung disease (ILD), a type of scarring and inflammation in the lungs that can make breathing difficult. Many people also develop muscle weakness (a condition called inflammatory myopathy or myositis), painful and swollen joints (arthritis), and a distinctive skin change on the hands called 'mechanic's hands,' where the skin becomes rough, cracked, and thickened. Some people develop Raynaud's phenomenon, where fingers and toes turn white or blue in the cold. Treatment focuses on calming the immune system using medications called immunosuppressants. Common treatments include corticosteroids like prednisone, and other drugs such as azathioprine, mycophenolate mofetil, methotrexate, rituximab, and tacrolimus. There is currently no cure, but many people can achieve good disease control with the right treatment plan. Early diagnosis and treatment are very important to protect the lungs and muscles.

Also known as:

Key symptoms:

Muscle weakness, especially in the shoulders, hips, and thighsShortness of breath or dry cough due to lung inflammationJoint pain and swelling, especially in the hands and fingersRough, cracked, thickened skin on the fingers and palms ('mechanic's hands')Fingers or toes turning white, blue, or red in cold temperatures (Raynaud's phenomenon)Fever, especially at the start of the diseaseFatigue and general tirednessDifficulty swallowing in some casesSkin rash on the face, chest, or hands (similar to dermatomyositis)Unintended weight loss

Clinical phenotype terms (44)— hover any for plain English
Abnormal pulmonary interstitial morphologyHP:0006530MyositisHP:0100614Raynaud phenomenonHP:0030880
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Aug 2026Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

The Netherlands Cancer Institute — PHASE1

TrialNOT YET RECRUITING
Jun 2026Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment

University of Aarhus — NA

TrialNOT YET RECRUITING
May 2026Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols Diet

Wake Forest University Health Sciences — NA

TrialNOT YET RECRUITING
May 2026A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Nielsen Fernandez-Becker — PHASE1

TrialNOT YET RECRUITING
Apr 2026Aminoglycosides in Early Sepsis

University Hospital, Akershus — PHASE4

TrialNOT YET RECRUITING
Apr 2026Exercise as Medicine for Pediatric Chronic Pain

Boston Children's Hospital — NA

TrialNOT YET RECRUITING
Mar 2026Descartes-08 in Autoantibody Myositis

Cartesian Therapeutics — PHASE2

TrialNOT YET RECRUITING
Feb 2026A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome

China-Japan Friendship Hospital — NA

TrialNOT YET RECRUITING
Feb 2026Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis

Ain Shams University — PHASE3

TrialNOT YET RECRUITING
Jan 2026Dietary Intervention Using a Gluten-free App to Improve Tracking, Adherence, and Learning(DIGITAL) Study

Boston Children's Hospital — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Antisynthetase syndrome.

5 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

5 recruitingView all trials with filters →
Other2 trials
Evaluation of Circulating Neutrophils in Antisynthetase Syndrome
Actively Recruiting
PI: Paul Decker, MD (CHU NANCY) · Sites: Nancy · Age: 1899 yrs
Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease
Actively Recruiting
PI: Paul Decker, MD (CHU NANCY) · Sites: Dijon; Metz +4 more · Age: 1899 yrs

Specialists

Showing 25 of 35View all specialists →
LB
Lawrence H Brent
CRANBURY, NJ
Specialist
1 Antisynthetase syndrome publication
GK
Gerhard Krönke
Specialist
2 Antisynthetase syndrome publications
WS
Werner Stenzel
Specialist
2 Antisynthetase syndrome publications
LG
Laure Gallay
Specialist
2 Antisynthetase syndrome publications
IL
Ingrid E Lundberg
Specialist
2 Antisynthetase syndrome publications
GS
Gianluca Sambataro
Specialist
2 Antisynthetase syndrome publications
SB
Sangmee Sharon Bae
LOS ANGELES, CA
Specialist
2 Antisynthetase syndrome publications
CO
Chester V Oddis
PITTSBURGH, PA
Specialist
2 Antisynthetase syndrome publications
RA
Rohit Aggarwal
PITTSBURGH, PA
Specialist
2 Antisynthetase syndrome publications
JL
Jian-Qiang Lu
Specialist
2 Antisynthetase syndrome publications
PP
Puja Patel
Specialist
1 Antisynthetase syndrome publication
JM
Jenna M Marinock
PHILADELPHIA, PA
Specialist
1 Antisynthetase syndrome publication
AA
Aamir Ajmeri
PHILADELPHIA, PA
Specialist
1 Antisynthetase syndrome publication
AP
Ann-Christin Pecher
Specialist
1 Antisynthetase syndrome publication
LH
Luca Hensen
Specialist
1 Antisynthetase syndrome publication
SP
Samuel K Shinjo, PhD
Specialist
PI on 3 active trials
AP
Apostolos Armaganidis, MD, PhD
Specialist
PI on 2 active trials
BP
Brendan Lee, MD, PhD
Specialist
PI on 4 active trials
SM
Siqing Fu, MD
HOUSTON, TX
Specialist
PI on 2 active trials
RM
Rainard Fuhr, Dr. med.
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Antisynthetase syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Antisynthetase syndromeForum →

No community posts yet. Be the first to share your experience with Antisynthetase syndrome.

Start the conversation →

Latest news about Antisynthetase syndrome

Disease timeline:

New recruiting trial: Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: PBMC as Biomarkers of Diabetic Cardiomyopathy

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Acupuncture First for IC/BPS

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Convalescent Plasma as a Possible Treatment for COVID-19

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Periodic Fasting for Treatment of Long Covid in Adults: a Pilot Study

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes

A new clinical trial is recruiting patients for Antisynthetase syndrome

New recruiting trial: Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

A new clinical trial is recruiting patients for Antisynthetase syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which antisynthetase antibody do I have, and what does that mean for my specific risks and prognosis?,How severe is my lung involvement right now, and how often should my lungs be monitored?,What is the goal of my treatment — to achieve remission, or to slow progression?,What are the main side effects of the medications you are recommending, and how will we manage them?,Should I see a pulmonologist in addition to a rheumatologist, and how will these specialists coordinate my care?,Are there any clinical trials I might be eligible for?,What warning signs should prompt me to seek emergency care or contact you urgently?

Common questions about Antisynthetase syndrome

What is Antisynthetase syndrome?

Antisynthetase syndrome (also sometimes called anti-synthetase syndrome or ASS) is a rare autoimmune disease. This means the body's immune system mistakenly attacks its own healthy tissues. The disease gets its name from special proteins called aminoacyl-tRNA synthetases — the immune system produces antibodies that target these proteins, causing widespread inflammation. The syndrome mainly affects the muscles, lungs, joints, and skin. The most serious complication is interstitial lung disease (ILD), a type of scarring and inflammation in the lungs that can make breathing difficult. Many peopl

How is Antisynthetase syndrome inherited?

Antisynthetase syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Antisynthetase syndrome typically begin?

Typical onset of Antisynthetase syndrome is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Antisynthetase syndrome?

Yes — 5 recruiting clinical trials are currently listed for Antisynthetase syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Antisynthetase syndrome?

25 specialists and care centers treating Antisynthetase syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.